This study identified two potential prognosis-related TAAs, ARPC1B, and HK3, correlated to the immune infiltration level, screened out from overexpressed genes with mutation and CNV in GBM, and validated their expression at protein level by immunohistochemical staining. The gene discussed is ARPC1B; the disease is glioblastoma.